India, Sept. 15 -- ZyVet' Animal Health, a leader in affordable generic pharmaceuticals for animals, a wholly owned subsidiary of Zydus Pharmaceuticals (USA) Inc., itself a wholly owned subsidiary of Zydus Lifesciences, a global innovation led healthcare company, has released the first FDA-approved generic of phenylpropanolamine hydrochloride tablets, a trusted treatment for managing urinary incontinence in dogs. This latest product underscores ZyVet's mission to bring trusted, high-quality, and cost-effective therapies to veterinary professionals across the United States.Phenylpropanolamine hydrochloride is commonly prescribed to treat urinary incontinence in dogs due to urethral sphincter hypotonus. Often seen in spayed females and aging ...